<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for AstraZeneca plc - Google Finance</title>
<description>News for AstraZeneca plc - Google Finance</description>
<link>http://www.google.com/finance?q=LON:AZN&amp;amp;client=news-rss&amp;amp;ei=KOOXUdg2otjRAZ-jAQ</link>
<image>
<title>News for AstraZeneca plc - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=LON:AZN&amp;amp;client=news-rss&amp;amp;ei=KOOXUdg2otjRAZ-jAQ</link>
</image>
<item>
<title>AstraZeneca plc (ADR) (AZN): Where Investment Dollars Are Headed</title>
<link>http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azn-where-investment-dollars-are-headed-139911/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982058456533</guid>
<pubDate>Mon, 13 May 2013 01:40:32 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.insidermonkey.com/blog/astrazeneca-plc-adr-azn-where-investment-dollars-are-headed-139911/&quot; style=&quot;font-size:1.2em&quot;&gt;AstraZeneca plc (ADR) (AZN): Where Investment Dollars Are Headed&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Insider Monkey (blog)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;AstraZeneca plc (ADR) (NYSE:AZN) As I noted 10 weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing since 1991 thanks to access to more effective medications and ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>A Closer Look At AstraZeneca Plc&amp;#39;s Dividend Potential</title>
<link>http://www.fool.co.uk/news/investing/2013/05/14/a-closer-look-at-astrazeneca-plcs-dividend-potenti.aspx</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982060364044</guid>
<pubDate>Tue, 14 May 2013 10:46:04 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.fool.co.uk/news/investing/2013/05/14/a-closer-look-at-astrazeneca-plcs-dividend-potenti.aspx&quot; style=&quot;font-size:1.2em&quot;&gt;A Closer Look At AstraZeneca Plc&amp;#39;s Dividend Potential&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Motley Fool UK&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 14, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Is AstraZeneca plc (LON: AZN) a solid pick for dividend growth? Dividend income accounts for around two-thirds of total returns, the actual rate of return taking into account both capital and income appreciation.&lt;/div&gt;
&lt;a href=&quot;http://www.fool.com/investing/international/2013/05/12/a-closer-look-at-glaxosmithklines-dividend-potenti.aspx&quot;&gt;A Closer Look at GlaxoSmithKline&amp;#39;s Dividend Potential&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Motley Fool&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>ASTRAZENECA PLC : Sub-Group Analysis Shows Investigational Metreleptin ...</title>
<link>http://www.4-traders.com/ASTRAZENECA-PLC-4000930/news/AstraZeneca-plc-Sub-Group-Analysis-Shows-Investigational-Metreleptin-Treatment-Demonstrated-Reduct-16827422/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778145771563</guid>
<pubDate>Mon, 06 May 2013 11:10:49 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/ASTRAZENECA-PLC-4000930/news/AstraZeneca-plc-Sub-Group-Analysis-Shows-Investigational-Metreleptin-Treatment-Demonstrated-Reduct-16827422/&quot; style=&quot;font-size:1.2em&quot;&gt;ASTRAZENECA PLC : Sub-Group Analysis Shows Investigational Metreleptin ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 6, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced the results from a 12-month sub-group analysis of a National Institutes of Health (NIH), open-label, long-term research study of metreleptin, an investigational ...&lt;/div&gt;
&lt;a href=&quot;http://online.wsj.com/article/BT-CO-20130506-702628.html?mod=googlenews_wsj&quot;&gt;Bristol-Myers, AstraZeneca: Study Shows Metreleptin May Treat Pediatric ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Wall Street Journal&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Is AstraZeneca Plc The Ultimate Stock-Pickers Share?</title>
<link>http://www.fool.co.uk/news/investing/2013/04/29/is-astrazeneca-plc-the-ultimate-stock-pickers-shar.aspx</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778140276726</guid>
<pubDate>Mon, 29 Apr 2013 09:56:18 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.fool.co.uk/news/investing/2013/04/29/is-astrazeneca-plc-the-ultimate-stock-pickers-shar.aspx&quot; style=&quot;font-size:1.2em&quot;&gt;Is AstraZeneca Plc The Ultimate Stock-Pickers Share?&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Motley Fool UK&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 29, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;The shares of AstraZeneca plc (LON:AZN) pass a large number of popular investment screens. Does this mean that they are set to rocket?&lt;/div&gt;
&lt;a href=&quot;http://www.fool.com/investing/international/2013/04/29/is-astrazeneca-the-ultimate-stock-pickers-share.aspx&quot;&gt;Is AstraZeneca the Ultimate Stock Picker&amp;#39;s Share?&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Motley Fool&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>AstraZeneca sales drop 13% in first quarter</title>
<link>http://www.delawareonline.com/article/20130425/BUSINESS13/304250059/AstraZeneca-sales-drop-13-first-quarter</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778129300480</guid>
<pubDate>Thu, 25 Apr 2013 09:49:28 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.delawareonline.com/article/20130425/BUSINESS13/304250059/AstraZeneca-sales-drop-13-first-quarter&quot; style=&quot;font-size:1.2em&quot;&gt;AstraZeneca sales drop 13% in first quarter&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;The News Journal&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 25, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;LONDON - AstraZeneca Plc, the U.K.&amp;#39;s second-biggest pharmaceutical company, reported first-quarter sales that missed analysts&amp;#39; estimates as some of its best-selling medicines faced generic competition.&lt;/div&gt;
&lt;a href=&quot;http://online.wsj.com/article/SB10001424127887324474004578444133135013720.html&quot;&gt;Mixed Results for Drug Companies&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Wall Street Journal&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.reuters.com/article/2013/04/25/us-astrazeneca-results-idUSBRE93O05220130425&quot;&gt;AstraZeneca hit by generic drugs and Crestor shortfall&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Reuters&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>AstraZeneca Plc + BG Group plc lead morning broker upgrade board; AZN ...</title>
<link>http://www.economy-news.co.uk/shares/share-price-drivers/3429-astrazeneca-plc-and-bg-group-plc-broker-upgrades-443543</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.economy-news.co.uk/shares/share-price-drivers/3429-astrazeneca-plc-and-bg-group-plc-broker-upgrades-443543</guid>
<pubDate>Wed, 15 May 2013 09:14:33 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.economy-news.co.uk/shares/share-price-drivers/3429-astrazeneca-plc-and-bg-group-plc-broker-upgrades-443543&quot; style=&quot;font-size:1.2em&quot;&gt;AstraZeneca Plc + BG Group plc lead morning broker upgrade board; AZN ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Economy News&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 15, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;AstraZeneca plc (LON:AZN) shares are trading 0.97 pct higher than seen at Friday&amp;#39;s close; AZN is at 3,373.98 at 9:50 in London.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Why Unilever plc, AstraZeneca plc And Kier Group plc Should Lag The FTSE ...</title>
<link>http://www.fool.co.uk/news/investing/2013/04/25/why-unilever-plc-astrazeneca-plc-and-kier-group-pl.aspx</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778131567371</guid>
<pubDate>Thu, 25 Apr 2013 12:02:29 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.fool.co.uk/news/investing/2013/04/25/why-unilever-plc-astrazeneca-plc-and-kier-group-pl.aspx&quot; style=&quot;font-size:1.2em&quot;&gt;Why Unilever plc, AstraZeneca plc And Kier Group plc Should Lag The FTSE ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Motley Fool UK&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 25, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Unilever plc (LON: ULVR), AstraZeneca plc (LON: AZN) and Kier Group plc (LON: KIE) are all falling. The FTSE 100 dipped early this morning, despite the news that the UK economy has so far avoided a triple-dip recession by growing 0.3% in the first ...&lt;/div&gt;
&lt;a href=&quot;http://www.economy-news.co.uk/shares/share-price-drivers/3260-astrazeneca-plc-taylor-wimpey-plc-results-4354353&quot;&gt;AstraZeneca plc + Taylor Wimpey plc : AZN and TW stock see differing fortunes ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Economy News&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>ASTRAZENECA PLC : AstraZeneca and BIND Therapeutics announce ...</title>
<link>http://www.4-traders.com/ASTRAZENECA-PLC-4000930/news/AstraZeneca-plc-AstraZeneca-and-BIND-Therapeutics-announce-worldwide-development-and-commercialisa-16748130/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778128021892</guid>
<pubDate>Mon, 22 Apr 2013 07:51:57 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/ASTRAZENECA-PLC-4000930/news/AstraZeneca-plc-AstraZeneca-and-BIND-Therapeutics-announce-worldwide-development-and-commercialisa-16748130/&quot; style=&quot;font-size:1.2em&quot;&gt;ASTRAZENECA PLC : AstraZeneca and BIND Therapeutics announce ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 22, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;AstraZeneca and BIND Therapeutics announced today that they have entered into a strategic collaboration to develop and commercialise an Accurin™, a targeted and programmable cancer nanomedicine from BIND&amp;#39;s Medicinal Nanoengineering platform, ...&lt;/div&gt;
&lt;a href=&quot;http://www.bioworld.com/content/bind%E2%80%99s-accurin-platform-lands-200m-astrazeneca-partnership-1&quot;&gt;BIND&amp;#39;s Accurin Platform Lands $200M AstraZeneca Partnership&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;BioWorld Online&lt;/span&gt;&lt;br&gt;
&lt;a href=&quot;http://www.boston.com/businessupdates/2013/04/22/astrazeneca-collaboration-with-bind-therapeutics-will-focus-cancer-nanomedicine/BLJAUAUttkRQQSKc5O7dhJ/story.html&quot;&gt;AstraZeneca collaboration with Bind Therapeutics will focus on cancer ...&lt;/a&gt; - &lt;span style=&quot;color:#888888&quot;&gt;Boston.com&lt;/span&gt;&lt;br&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>3 FTSE Shares Hitting New Highs: AstraZeneca plc, Telecom Plus PLC And ...</title>
<link>http://www.fool.co.uk/news/investing/2013/04/19/3-ftse-shares-hitting-new-highs-astrazeneca-plc-te.aspx</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778125101803</guid>
<pubDate>Fri, 19 Apr 2013 13:43:00 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.fool.co.uk/news/investing/2013/04/19/3-ftse-shares-hitting-new-highs-astrazeneca-plc-te.aspx&quot; style=&quot;font-size:1.2em&quot;&gt;3 FTSE Shares Hitting New Highs: AstraZeneca plc, Telecom Plus PLC And ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Motley Fool UK&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 19, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;AstraZeneca plc (LON: AZN), Telecom Plus PLC (LON: TEP) and Barratt Developments Plc (LON: BDEV) are flying. It&amp;#39;s little more than a month since the FTSE 100 set a new five-year record of 6,534 points, on 12 March.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Director Deals - AstraZeneca PLC (AZN)</title>
<link>http://www.stockmarketwire.com/article/4584126/Director-Deals-AstraZeneca-PLC-AZN.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778132765206</guid>
<pubDate>Mon, 29 Apr 2013 14:18:19 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.stockmarketwire.com/article/4584126/Director-Deals-AstraZeneca-PLC-AZN.html&quot; style=&quot;font-size:1.2em&quot;&gt;Director Deals - AstraZeneca PLC (AZN)&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Stock Market Wire&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 29, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Director Deals - AstraZeneca PLC (AZN). 29 April 2013 | 15:15pm. StockMarketWire.com - Simon Lowth, Financial Director, sold post-exercise 54,561 shares in the company on the 26th April 2013 at a price of 3316.00p.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
